Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

NCT03116997 ·Status: COMPLETED ·Phase: PHASE3

Reversal of Neuromuscular Blockade in Thoracic Surgical Patients

NCT01837498 ·Status: COMPLETED

Sugammadex Improves Muscle Function After Standard Neuromuscular Recovery

NCT01101139 ·Status: COMPLETED ·Phase: PHASE4

Reversal of Moderate or Superficial Neuromuscular Blockade Induced by Cisatracurium

NCT04920682 ·Status: COMPLETED ·Phase: PHASE4

Electromyography in Patients on Chronic Pyridostigmine Therapy

NCT02364180 ·Status: COMPLETED ·Phase: NA

Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular

NCT03322657 ·Status: COMPLETED ·Phase: PHASE4

Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial

NCT06136585 ·Status: RECRUITING ·Phase: PHASE3

Cerebral Oxygenation and Metabolism After Reversal Of Rocuronium: Comparison Between Sugammadex Versus Neostigmine

NCT02944175 ·Status: UNKNOWN ·Phase: NA

A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy

NCT06169046 ·Status: RECRUITING ·Phase: PHASE2

A Single Ascending Dose of HRS-2162 in Healthy Subjects

NCT07195604 ·Status: RECRUITING ·Phase: PHASE1

Effect of Magnesium Sulphate on Neostigmine

NCT03020706 ·Status: UNKNOWN ·Phase: NA

Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis

NCT02542787 ·Status: COMPLETED ·Phase: PHASE2

Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients

NCT03781479 ·Status: COMPLETED ·Phase: PHASE2

Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery

NCT06745492 ·Status: COMPLETED

Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration

NCT05219487 ·Status: COMPLETED

SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4

NCT02941328 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess FLX-787 in Subjects With Motor Neuron Disease Experiencing Muscle Cramps.

NCT03196375 ·Status: TERMINATED ·Phase: PHASE2

Safety Study of HPP593 in Subjects During and After Limb Immobilization

NCT01524406 ·Status: TERMINATED ·Phase: PHASE1

A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

NCT01549847 ·Status: WITHDRAWN ·Phase: PHASE3

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

NCT03346057 ·Status: COMPLETED ·Phase: PHASE4

Neostigmine Reversal And Neuromuscular Recovery

NCT02433808 ·Status: COMPLETED ·Phase: PHASE4

Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)

NCT01084551 ·Status: COMPLETED ·Phase: PHASE3

Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3

NCT03819660 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT04003974 ·Status: COMPLETED ·Phase: PHASE2

An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1 (NCT01494701)

NCT01780246 ·Status: COMPLETED ·Phase: PHASE1